Francisco M Almazán-Fernández

5PUBLICATIONS
22CO-AUTHORS
Molecular targetsTraditional Chinese medicine and treatmentsImmunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 09, 2026
Clinical Outcomes of Sonidegib in Vismodegib-Exposed Locally Advanced Basal Cell Carcinoma: Insights From a Multicenter Descriptive Study.

Alvaro Prados-Carmona, María Martínez-Pérez, J Pablo Velasco-Amador

|Apr 03, 2025
Optimising Actinic Cheilitis Management: Balancing Efficacy, Safety, and Patient Adherence With Topical Tirbanibulin.

Alvaro Prados-Carmona, Francisco M Almazán-Fernández, Pablo Velasco-Amador

|May 13, 2024
Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study.

Antonio Tejera-Vaquerizo, Álvaro Gómez-Tomás, Ane Jaka

|Oct 11, 2021
HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma.

Xu Wang, Francisco Almazan, Yoel Genaro Montoyo-Pujol

|Feb 12, 2021
Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis.

Xu Wang, Yoel Genaro Montoyo-Pujol, Sandra Bermudez

Pageof 1